Our 3rd Data Partner Call is now closed! Next Call in 2021


New Academy course now available: Phenotype Definition, Characterisation and Evaluation!

We are pleased to announce that we’ve just launched the next course in the...

Read More
Nature COVID-19
EHDEN Partners collaborate within OHDSI on COVID-19: new paper in Nature on deep phenotyping of COVID-19 patients

Hospitalized COVID-19 Patients Shown To Be Younger, Healthier Than Influenza Patients Per Recent Global...

Read More
EHDEN Certifies another 5 European SMEs in the mapping of data to the OMOP CDM.

Last week, September 22-23, we had a second training and certification meeting for the...

Read More
Launch of our 3rd open call for data partners

15 September 2020, Brussels, Belgium: The EHDEN Consortium would like to invite all data...

Read More

Posts Navigation

Welcome to the European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 22 partners which will operate in Europe for the coming five years, 2018 – 2024.

EHDEN was launched to address the current challenges in generating insights and evidence from real-world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the pharmaceutical industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices.

At this time, the thoughts of all those involved in the EHDEN project are with those ill with COVID-19, and those who are looking after them at home or in hospitals.

Clearly, we are all affected by this evolving pandemic, and equally, the project will be impacted by it, but we will aim to mitigate this as best as practicable.

EHDEN is proud to have collaborated with OHDSI colleagues in ongoing studies since March on COVID-19, see more information here and on the OHDSI website here.

Our best wishes to all, stay safe and well.



No event found!